Identifying the immune interactions underlying HLA class I disease associations

Area of Science:

• Immunogenetics
• Molecular immunology
• Disease association studies

Background:

• Polymorphisms in Human Leukocyte Antigen (HLA) class I loci significantly influence susceptibility and severity of autoimmune diseases, malignancies, and infections.
• Current interpretations often focus on CD8+ T cell responses restricted by HLA class I allotypes, potentially overlooking other crucial interactions.

Purpose of the Study:

• To develop and apply an immunogenetic approach for dissecting the contributions of various receptor-ligand interactions to HLA class I disease associations.
• To investigate the immune mechanisms underlying HLA class I associations in viral infections (HTLV-1, HIV-1, HCV) and Crohn's disease.

Main Methods:

• Development of a novel immunogenetic framework to quantify the relative impact of different receptor-ligand pairs.
• Application of this framework to analyze HLA class I associations in specific viral infections and an inflammatory disease.

Main Results:

• The study establishes a method to differentiate the roles of T cell receptors, killer immunoglobulin-like receptors (KIRs), CD94:NKG2 receptors, and leukocyte immunoglobulin-like receptors (LILRs) in HLA class I disease associations.
• Analysis reveals the complex interplay of these interactions in the context of Human T cell Leukemia Virus type 1, Human Immunodeficiency Virus type 1, Hepatitis C Virus, and Crohn's disease.

Conclusions:

• HLA class I associations with disease are mediated by a broader spectrum of immune receptor interactions than previously emphasized.
• This approach provides a more comprehensive understanding of the immunogenetic basis of various human diseases, paving the way for targeted therapeutic strategies.